Cargando…

BMP4-SMAD1/5/9-RUNX2 pathway activation inhibits neurogenesis and oligodendrogenesis in Alzheimer’s patients’ iPSCs in senescence-related conditions

Detalles Bibliográficos
Autores principales: Nakatsu, Daiki, Kunishige, Rina, Taguchi, Yuki, Shinozaki-Narikawa, Naeko, Osaka, Kishiko, Yokomizo, Kayo, Ishida, Mami, Takei, Shunsuke, Yamasaki, Shoko, Hagiya, Keita, Hattori, Kotaro, Tsukamoto, Tadashi, Murata, Masayuki, Kano, Fumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202651/
https://www.ncbi.nlm.nih.gov/pubmed/37163982
http://dx.doi.org/10.1016/j.stemcr.2023.03.017
_version_ 1785045468165701632
author Nakatsu, Daiki
Kunishige, Rina
Taguchi, Yuki
Shinozaki-Narikawa, Naeko
Osaka, Kishiko
Yokomizo, Kayo
Ishida, Mami
Takei, Shunsuke
Yamasaki, Shoko
Hagiya, Keita
Hattori, Kotaro
Tsukamoto, Tadashi
Murata, Masayuki
Kano, Fumi
author_facet Nakatsu, Daiki
Kunishige, Rina
Taguchi, Yuki
Shinozaki-Narikawa, Naeko
Osaka, Kishiko
Yokomizo, Kayo
Ishida, Mami
Takei, Shunsuke
Yamasaki, Shoko
Hagiya, Keita
Hattori, Kotaro
Tsukamoto, Tadashi
Murata, Masayuki
Kano, Fumi
author_sort Nakatsu, Daiki
collection PubMed
description
format Online
Article
Text
id pubmed-10202651
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-102026512023-05-23 BMP4-SMAD1/5/9-RUNX2 pathway activation inhibits neurogenesis and oligodendrogenesis in Alzheimer’s patients’ iPSCs in senescence-related conditions Nakatsu, Daiki Kunishige, Rina Taguchi, Yuki Shinozaki-Narikawa, Naeko Osaka, Kishiko Yokomizo, Kayo Ishida, Mami Takei, Shunsuke Yamasaki, Shoko Hagiya, Keita Hattori, Kotaro Tsukamoto, Tadashi Murata, Masayuki Kano, Fumi Stem Cell Reports Correction Elsevier 2023-05-09 /pmc/articles/PMC10202651/ /pubmed/37163982 http://dx.doi.org/10.1016/j.stemcr.2023.03.017 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Correction
Nakatsu, Daiki
Kunishige, Rina
Taguchi, Yuki
Shinozaki-Narikawa, Naeko
Osaka, Kishiko
Yokomizo, Kayo
Ishida, Mami
Takei, Shunsuke
Yamasaki, Shoko
Hagiya, Keita
Hattori, Kotaro
Tsukamoto, Tadashi
Murata, Masayuki
Kano, Fumi
BMP4-SMAD1/5/9-RUNX2 pathway activation inhibits neurogenesis and oligodendrogenesis in Alzheimer’s patients’ iPSCs in senescence-related conditions
title BMP4-SMAD1/5/9-RUNX2 pathway activation inhibits neurogenesis and oligodendrogenesis in Alzheimer’s patients’ iPSCs in senescence-related conditions
title_full BMP4-SMAD1/5/9-RUNX2 pathway activation inhibits neurogenesis and oligodendrogenesis in Alzheimer’s patients’ iPSCs in senescence-related conditions
title_fullStr BMP4-SMAD1/5/9-RUNX2 pathway activation inhibits neurogenesis and oligodendrogenesis in Alzheimer’s patients’ iPSCs in senescence-related conditions
title_full_unstemmed BMP4-SMAD1/5/9-RUNX2 pathway activation inhibits neurogenesis and oligodendrogenesis in Alzheimer’s patients’ iPSCs in senescence-related conditions
title_short BMP4-SMAD1/5/9-RUNX2 pathway activation inhibits neurogenesis and oligodendrogenesis in Alzheimer’s patients’ iPSCs in senescence-related conditions
title_sort bmp4-smad1/5/9-runx2 pathway activation inhibits neurogenesis and oligodendrogenesis in alzheimer’s patients’ ipscs in senescence-related conditions
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202651/
https://www.ncbi.nlm.nih.gov/pubmed/37163982
http://dx.doi.org/10.1016/j.stemcr.2023.03.017
work_keys_str_mv AT nakatsudaiki bmp4smad159runx2pathwayactivationinhibitsneurogenesisandoligodendrogenesisinalzheimerspatientsipscsinsenescencerelatedconditions
AT kunishigerina bmp4smad159runx2pathwayactivationinhibitsneurogenesisandoligodendrogenesisinalzheimerspatientsipscsinsenescencerelatedconditions
AT taguchiyuki bmp4smad159runx2pathwayactivationinhibitsneurogenesisandoligodendrogenesisinalzheimerspatientsipscsinsenescencerelatedconditions
AT shinozakinarikawanaeko bmp4smad159runx2pathwayactivationinhibitsneurogenesisandoligodendrogenesisinalzheimerspatientsipscsinsenescencerelatedconditions
AT osakakishiko bmp4smad159runx2pathwayactivationinhibitsneurogenesisandoligodendrogenesisinalzheimerspatientsipscsinsenescencerelatedconditions
AT yokomizokayo bmp4smad159runx2pathwayactivationinhibitsneurogenesisandoligodendrogenesisinalzheimerspatientsipscsinsenescencerelatedconditions
AT ishidamami bmp4smad159runx2pathwayactivationinhibitsneurogenesisandoligodendrogenesisinalzheimerspatientsipscsinsenescencerelatedconditions
AT takeishunsuke bmp4smad159runx2pathwayactivationinhibitsneurogenesisandoligodendrogenesisinalzheimerspatientsipscsinsenescencerelatedconditions
AT yamasakishoko bmp4smad159runx2pathwayactivationinhibitsneurogenesisandoligodendrogenesisinalzheimerspatientsipscsinsenescencerelatedconditions
AT hagiyakeita bmp4smad159runx2pathwayactivationinhibitsneurogenesisandoligodendrogenesisinalzheimerspatientsipscsinsenescencerelatedconditions
AT hattorikotaro bmp4smad159runx2pathwayactivationinhibitsneurogenesisandoligodendrogenesisinalzheimerspatientsipscsinsenescencerelatedconditions
AT tsukamototadashi bmp4smad159runx2pathwayactivationinhibitsneurogenesisandoligodendrogenesisinalzheimerspatientsipscsinsenescencerelatedconditions
AT muratamasayuki bmp4smad159runx2pathwayactivationinhibitsneurogenesisandoligodendrogenesisinalzheimerspatientsipscsinsenescencerelatedconditions
AT kanofumi bmp4smad159runx2pathwayactivationinhibitsneurogenesisandoligodendrogenesisinalzheimerspatientsipscsinsenescencerelatedconditions